Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antianaphylaxis(antihistamines) and antidotes > Canagliflozin
Canagliflozin
Inquiry
| Post Date: | Oct 06,2013 |
| Expiry Date: | Oct 06,2014 |
| Detailed Description: |
Cas No. :842133-18-0
Specs:Min purity 99%-inhouse specs Canagliflozin is a drug for the treatment of type 2 diabetes . Canagliflozin is an inhibitor of subtype 2 sodium-glucose transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter causes blood glucose to be eliminated through the urine. In March 2013, Canagliflozin became the first SGLT2 inhibitor to be approved in the United States. |
| CAS Registry Number: | 842133-18-0 |
| Synonyms: | ;(1s)-1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-d-glucitol;1-(β-D-glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienyl-methyl) benzene;(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol;Canaglifozin; |
| Molecular Formula: | C24H25FO5S |
| Molecular Weight: | 444.52 |
| Molecular Structure: | 
|
| Company: | Stereokem [ United States ] |
| Contact: | Sundar |
| Tel: | +1-415-290-0331 |
| Fax: | |
| Email: | gideon@stereokem.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
